Furthermore, the risk score curve and Kaplan-Meier analysis demonstrated that lung cancer patients with heightened ZNF131 expression exhibited significantly reduced survival times and rates in comparison to those with lower ZNF131 expression (Figure 2D and E). Here, ZBTB35 is linked to lung carcinoma.